Key result
Serum ceruloplasmin levels were significantly and positively associated with arterial stiffness (baPWV) in Korean men with type 2 diabetes mellitus (r = 0.109, P = 0.003).
Why the study?
Are serum ceruloplasmin levels associated with increased arterial stiffness in Korean men with type 2 diabetes mellitus?
Cross-Sectional (n=760)
Are serum ceruloplasmin levels associated with increased arterial stiffness in Korean men with type 2 diabetes mellitus?
Effect estimate: r = 0.109
p-value: p=0.003
Higher serum ceruloplasmin levels are independently associated with increased arterial stiffness in Korean men with type 2 diabetes.
May support ceruloplasmin as vascular biomarker in T2DM men; hypothesis-generating and should not yet change practice.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2012) conducted a cross-sectional in Type 2 diabetes mellitus (n=760). Serum ceruloplasmin levels vs. Lower serum ceruloplasmin levels was evaluated on Arterial stiffness measured by brachial-ankle pulse wave velocity (baPWV) (r = 0.109, p=0.003). Serum ceruloplasmin levels were significantly and positively associated with arterial stiffness (baPWV) in Korean men with type 2 diabetes mellitus (r = 0.109, P = 0.003).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: